Technology

Entera Bio

$1.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-3.98%) Today
+$0.15 (+8.88%) As of 10:14 AM UTC after-hours

Why Robinhood?

You can buy or sell Entera Bio and other stocks, options, and ETFs commission-free!

About ENTX

Entera Bio Ltd. Ordinary Shares, also called Entera Bio, is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel. The listed name for ENTX is Entera Bio Ltd. Ordinary Shares.

CEO
Spiros Jamas
Employees
24
Headquarters
Jerusalem, Jerusalem
Founded
2009
Market Cap
34.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
704.80K
High Today
$1.76
Low Today
$1.66
Open Price
$1.76
Volume
300.68K
52 Week High
$3.40
52 Week Low
$1.00

Collections

ENTX Earnings

-$0.26
-$0.17
-$0.09
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, Pre-Market

You May Also Like

FEDX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure